| 22-01-07 | Delisting of AS "Olainfarm” shares from the Baltic Main list | AQ |
| 22-01-06 | Notification about results of final buy-back of shares | AQ |
| 21-12-30 | Notification about final share buy-back | AQ |
| 21-12-28 | Correction: Regarding results of a share buy-back offer | AQ |
| 21-12-28 | On substantial participation (4) - specified | AQ |
| 1 day | -0.24% |
| Manager | Title | Age | Since |
|---|---|---|---|
Juris Hmelnickis
CEO | Chief Executive Officer | 46 | 2025-12-31 |
Janis Leimanis
DFI | Director of Finance/CFO | 56 | - |
| Chief Tech/Sci/R&D Officer | - | 2009-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Janis Buks
CHM | Chairman | - | 2022-08-31 |
| Director/Board Member | 63 | 2021-06-18 | |
Vadims Telica
BRD | Director/Board Member | 62 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.24% | -3.46% | - | - | 148M | |
| +0.44% | +0.79% | +6.13% | +82.35% | 44.99B | |
| +0.15% | -3.07% | +38.75% | +88.27% | 33.69B | |
| +0.46% | -1.10% | -9.10% | +42.72% | 11.68B | |
| +0.69% | +1.96% | +12.99% | +117.80% | 11.6B | |
| 0.00% | +0.39% | +36.53% | +125.55% | 8.94B | |
| -1.44% | -1.94% | +15.12% | +39.35% | 7.01B | |
| -1.50% | -0.83% | +39.74% | -18.82% | 6.51B | |
| +0.00% | -1.66% | +31.13% | +237.16% | 6.35B | |
| -0.45% | -2.96% | -39.97% | -6.82% | 5.15B | |
| Average | -0.16% | -0.93% | +14.59% | +78.62% | 15.1B | |
| Weighted average by Cap. | +0.17% | -1.81% | +16.99% | +83.07% |
Employees
2,191
Sector
Pharmaceuticals
